The Association of Plasma Levels of Liver Enzymes and Risk of Gestational Diabetes Mellitus: a Systematic Review and Dose-response Meta-analysis of Observational Studies
Overview
Authors
Affiliations
Aims: Relationship between liver enzymes such as gamma-glutamyl transferase (GGT), alanine aminotransferase (ALT), aspartate transaminase (AST) and alkaline phosphatase and risk of gestational diabetes mellitus (GDM) is a controversial issue. The aim of this systematic review and dose-response meta-analysis was to investigate the association between liver enzymes and risk of GDM in observational studies.
Methods: A comprehensive systematic literature search was conducted in MEDLINE/PubMed, SCOPUS and Web of Science databases up to September 2019. Combined odds ratios (ORs) with 95% confidence intervals (CIs) were evaluated by DerSimonian and Laird random-effects models. Dose-response analyses of these relationships were also carried out.
Results: Eight studies with 25,451 participants containing 2549 cases were included in this study. Pooled results showed a significant association between GGT levels and risk of GDM (OR 2.10, 95% CI 1.14-3.86, I 84%). In addition, random-effects model indicated a dramatic and direct significant association between GGT and risk of GDM in nonlinear (p < 0.001) and linear (p < 0.001) dose-response analysis. Associations between ALT and AST with risk of GDM were found to be non-significant (OR 1.32, 95% CI 0.91-1.90, I 65% and OR 0.76, 95% CI 0.52-1.10, I 16%, respectively).
Conclusion: This systematic review and dose-response meta-analysis highlights GGT as a significant and robust predictor of the incidence of GDM in pregnant women.
Liu H, Zhang L, Cheng H, Chi P, Zhuang Y, Alifu X Front Endocrinol (Lausanne). 2024; 15:1396347.
PMID: 38836232 PMC: 11148214. DOI: 10.3389/fendo.2024.1396347.
Wu P, Wang Y, Ye Y, Yang X, Huang Y, Ye Y BMC Med. 2023; 21(1):150.
PMID: 37069659 PMC: 10111672. DOI: 10.1186/s12916-023-02818-6.
Lee S, Yu J, Han K, Lee S, You S, Kim H Endocrinol Metab (Seoul). 2023; 38(1):129-138.
PMID: 36702473 PMC: 10008663. DOI: 10.3803/EnM.2022.1609.
Ren Z, Okyere S, Xie L, Wen J, Wang J, Chen Z Front Immunol. 2022; 13:837237.
PMID: 35242140 PMC: 8887768. DOI: 10.3389/fimmu.2022.837237.
ALT/AST as an Independent Risk Factor of Gestational Diabetes Mellitus Compared with TG/HDL-C.
Song S, Zhang Y, Qiao X, Duo Y, Xu J, Peng Z Int J Gen Med. 2022; 15:115-121.
PMID: 35023950 PMC: 8743491. DOI: 10.2147/IJGM.S332946.